|1.||Szalai, Judit: 2 articles (01/2011 - 10/2009)|
|2.||Rónai, András Z: 2 articles (01/2011 - 10/2009)|
|3.||Király, Kornél: 2 articles (01/2011 - 10/2009)|
|4.||Barna, István: 2 articles (01/2011 - 10/2009)|
|5.||Kozsurek, Márk: 1 article (01/2011)|
|6.||Luyten, Walter: 1 article (01/2011)|
|7.||Szentirmay, Apolka: 1 article (01/2011)|
|8.||Puskár, Zita: 1 article (01/2011)|
|9.||Lambeir, Anne-Marie: 1 article (01/2011)|
|10.||Dai, Bo: 1 article (11/2010)|
10/12/2009 - "The hyperalgesia, peaking at 180 min after injection, was fully reversed by intrathecal administration of 30 nmol/rat Ile-Pro-Ile. "
01/10/2011 - "We have reported previously that the dipeptidyl peptidase IV inhibitor Ile-Pro-Ile had an antihyperalgesic action in rats when given intrathecally in the carrageenan-induced hyperalgesia, as detected by the Randall-Selitto test. "
|3.||Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
06/01/2007 - "Diprotin A infusion into nonobese diabetic/severe combined immunodeficiency mice markedly enhances engraftment of human mobilized CD34+ peripheral blood cells."
06/01/2007 - "We show that injection of irradiated nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice with >or=2 micromol Diprotin A (a tripeptide specific inhibitor of CD26 protease activity) at the time of transplant of human granulocyte colony-stimulating factor (G-CSF) mobilized CD34(+) peripheral blood cells (CD34(+) PBCs) results in a >3.4-fold enhancement of engraftment of human cells. "
|1.||Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)
|2.||Granulocyte Colony-Stimulating Factor (G-CSF)